-
Je něco špatně v tomto záznamu ?
Prevention of Neural Tube Defects in Europe: A Public Health Failure
JK. Morris, MC. Addor, E. Ballardini, I. Barisic, L. Barrachina-Bonet, P. Braz, C. Cavero-Carbonell, E. Den Hond, E. Garne, M. Gatt, M. Haeusler, B. Khoshnood, N. Lelong, A. Kinsner-Ovaskainen, S. Kiuru-Kuhlefelt, K. Klungsoyr, A....
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
34249803
DOI
10.3389/fped.2021.647038
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Objective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA. Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation. Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements. Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year.
Centre de Génétique Humaine Institut de Pathologie et de Génétique Charleroi Belgium
Department of Global Public Health and Primary Care University of Bergen Bergen Norway
Department of Medical Genetics Poznan University of Medical Sciences Poznan Poland
Department of Obstetrics and Gynaecology Medical University of Graz Graz Austria
Directorate for Health Information and Research Pietà Malta
Division of Mental and Physical Health Norwegian Institute of Public Health Bergen Norway
Epidemiology Department National Institute of Health Doutor Ricardo Jorge Lisboa Portugal
European Commission Joint Research Centre Ispra Italy
Health Department Provincial Institute of Hygiene Antwerp Belgium
Health Intelligence R and D Health Service Executive Dublin Ireland
Health Service Executive South Department of Public Health St Finbarr's Hospital Cork Ireland
Institute of Clinical Physiology National Research Council Pisa Italy
OMNI Net Ukraine Programs Rivne Ukraine
Paediatric Department Hospital Lillebaelt Kolding Kolding Denmark
Population Health Research Institute St George's University of London London United Kingdom
Population Health Sciences Institute Newcastle University Newcastle United Kingdom
Public Health England London United Kingdom
Spanish Collaborative Study of Congenital Malformations Instituto de Salud Carlos 3 Madrid Spain
Wessex Clinical Genetics Service Princess Anne Hospital Southampton United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024513
- 003
- CZ-PrNML
- 005
- 20211013133908.0
- 007
- ta
- 008
- 211006s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fped.2021.647038 $2 doi
- 035 __
- $a (PubMed)34249803
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Morris, Joan K $u Population Health Research Institute, St. George's, University of London, London, United Kingdom
- 245 10
- $a Prevention of Neural Tube Defects in Europe: A Public Health Failure / $c JK. Morris, MC. Addor, E. Ballardini, I. Barisic, L. Barrachina-Bonet, P. Braz, C. Cavero-Carbonell, E. Den Hond, E. Garne, M. Gatt, M. Haeusler, B. Khoshnood, N. Lelong, A. Kinsner-Ovaskainen, S. Kiuru-Kuhlefelt, K. Klungsoyr, A. Latos-Bielenska, E. Limb, MT. O'Mahony, I. Perthus, A. Pierini, J. Rankin, A. Rissmann, F. Rouget, G. Sayers, A. Sipek, S. Stevens, D. Tucker, C. Verellen-Dumoulin, HEK. de Walle, D. Wellesley, W. Wertelecki, E. Bermejo-Sanchez
- 520 9_
- $a Objective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA. Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation. Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements. Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Addor, Marie-Claude $u Department of Woman-Mother-Child, University Hospital Center, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
- 700 1_
- $a Ballardini, Elisa $u Indagine Sulle Malformazioni Congenite in Emilia-Romagna (IMER) Registry (Emilia Romagna Registry of Birth Defects) Neonatal Intensive Care Unit, Pediatric Section Department of Medical Sciences, University of Ferrara, Ferrara, Italy
- 700 1_
- $a Barisic, Ingeborg $u Centre of Excellence for Reproductive and Regenerative Medicine, Children's Hospital Zagreb, Medical School University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Barrachina-Bonet, Laia $u Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain
- 700 1_
- $a Braz, Paula $u Epidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisboa, Portugal
- 700 1_
- $a Cavero-Carbonell, Clara $u Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain
- 700 1_
- $a Den Hond, Elly $u Health Department, Provincial Institute of Hygiene, Antwerp, Belgium
- 700 1_
- $a Garne, Ester $u Paediatric Department, Hospital Lillebaelt Kolding, Kolding, Denmark
- 700 1_
- $a Gatt, Miriam $u Directorate for Health Information and Research, Pietà, Malta
- 700 1_
- $a Haeusler, Martin $u Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria
- 700 1_
- $a Khoshnood, Babak $u Université de Paris, Center of Research in Epidemiology and StatisticS/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France
- 700 1_
- $a Lelong, Nathalie $u Université de Paris, Center of Research in Epidemiology and StatisticS/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France
- 700 1_
- $a Kinsner-Ovaskainen, Agnieszka $u European Commission, Joint Research Centre, Ispra, Italy
- 700 1_
- $a Kiuru-Kuhlefelt, Sonja $u Finnish Institute for Health and Welfare Terveyden Ja Hyvinvoinnin Laitos (THL), Register of Congenital Malformations, Helsinki, Finland
- 700 1_
- $a Klungsoyr, Kari $u Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway $u Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway
- 700 1_
- $a Latos-Bielenska, Anna $u Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland
- 700 1_
- $a Limb, Elizabeth $u Population Health Research Institute, St. George's, University of London, London, United Kingdom
- 700 1_
- $a O'Mahony, Mary T $u Health Service Executive-South, Department of Public Health, St. Finbarr's Hospital, Cork, Ireland
- 700 1_
- $a Perthus, Isabelle $u Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, CHU Estaing, Clermont-Ferrand, France
- 700 1_
- $a Pierini, Anna $u Institute of Clinical Physiology, National Research Council, Pisa, Italy
- 700 1_
- $a Rankin, Judith $u Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom
- 700 1_
- $a Rissmann, Anke $u Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University, Magdeburg, Germany
- 700 1_
- $a Rouget, Florence $u Brittany Registry of Congenital Anomalies, CHU Rennes, Univ Rennes, INSERM, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France
- 700 1_
- $a Sayers, Gerardine $u Health Intelligence R&D Health Service Executive, Dublin, Ireland
- 700 1_
- $a Sipek, Antonin $u Department of Medical Biology and Genetics, 1st Faculty of Medicine, General University Hospital, Charles University, Prague, Czechia
- 700 1_
- $a Stevens, Sarah $u Public Health England, London, United Kingdom
- 700 1_
- $a Tucker, David $u Congenital Anomaly Register and Information Service for Wales, Public Health Wales Knowledge Directorate, Singleton Hospital, Swansea, United Kingdom
- 700 1_
- $a Verellen-Dumoulin, Christine $u Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi, Belgium
- 700 1_
- $a de Walle, Hermien E K $u Department of Genetics, Eurocat Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Wellesley, Diana $u Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom
- 700 1_
- $a Wertelecki, Wladimir $u OMNI-Net Ukraine Programs, Rivne, Ukraine
- 700 1_
- $a Bermejo-Sanchez, Eva $u Spanish Collaborative Study of Congenital Malformations (ECEMC), Unidad de Investigación sobre Anomalías Congénitas, Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, Madrid, Spain
- 773 0_
- $w MED00194312 $t Frontiers in pediatrics $x 2296-2360 $g Roč. 9, č. - (2021), s. 647038
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34249803 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20211013133905 $b ABA008
- 999 __
- $a ind $b bmc $g 1708352 $s 1145010
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 9 $c - $d 647038 $e 20210624 $i 2296-2360 $m Frontiers in pediatrics $n Front Pediatr $x MED00194312
- LZP __
- $a Pubmed-20211006